Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali

PHASE3CompletedINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

November 12, 2009

Primary Completion Date

June 26, 2010

Study Completion Date

July 26, 2010

Conditions
Infections, Streptococcal
Interventions
BIOLOGICAL

Pneumococcal vaccine GSK1024850A

Intramuscular injection, 1 or 2 doses

Trial Locations (1)

Unknown

GSK Investigational Site, Bamako

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00985465 - Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali | Biotech Hunter | Biotech Hunter